Sanofi

Q4 2025 13F-HR Holdings

Location
Paris, I0
Holdings as of
12/31/2025
Date filed
2/11/2026
Form type
13F-HR
Num holdings
8
Total value ($000)
$310,415
Net value change ($000)
+50,054 (19.2%)
New positions
1
Sold out positions
2
Turnover %
9.9%
Sector allocation + QoQ delta (equities-only)
Prev filing: 11/4/2025 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q3 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
INBX 52,477 134.6%
MPLT 16,020 NEW
ANAB 14,680 58.3%
QTTB 327 67.7%
Top Reduces (Value $000, Stocks/ETFs)
NVAX -13,417 -22.5%
OMDA -11,606 -100.0%
MGTX -3,415 -3.4%
LAVA Therapeutics NV -2,994 -100.0%
IMRX -1,138 -6.0%
ELDN -880 -41.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type